...Welcome To The Resverlogix HUB On AGORACOM!

**Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial (now fully enrolled) and Will Soon Begin Phase 2 Kidney Dialysis and Fabry Disease Trials**

Message: 15,000 @ $2.93

The reason for paying the premium instead of buying on the open market is that the shares purchased at premium are immediately deliverable thereby satisfying the delivery failure the premium paying purchaser has incurred. 

New Message
Please login to post a reply